X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (80) 80
male (66) 66
female (63) 63
oncology (58) 58
middle aged (57) 57
index medicus (52) 52
aged (50) 50
adult (49) 49
chemotherapy (35) 35
cancer (31) 31
aged, 80 and over (28) 28
treatment outcome (24) 24
antineoplastic combined chemotherapy protocols - therapeutic use (23) 23
survival (22) 22
fluorouracil - administration & dosage (20) 20
hematology, oncology and palliative medicine (19) 19
disease-free survival (18) 18
clinical trials (16) 16
kaplan-meier estimate (16) 16
colorectal neoplasms - drug therapy (15) 15
deoxycytidine - analogs & derivatives (15) 15
metastasis (15) 15
bevacizumab (14) 14
care and treatment (14) 14
colorectal neoplasms - pathology (14) 14
fluorouracil (14) 14
colorectal cancer (13) 13
oxaliplatin (13) 13
prognosis (13) 13
research (13) 13
adenocarcinoma (12) 12
adenocarcinoma - drug therapy (12) 12
animals (12) 12
antineoplastic combined chemotherapy protocols - adverse effects (12) 12
deoxycytidine - administration & dosage (12) 12
leucovorin (12) 12
metastases (12) 12
neoplasm staging (12) 12
pancreatic neoplasms - drug therapy (12) 12
rats (12) 12
survival analysis (12) 12
antibodies, monoclonal - administration & dosage (11) 11
double-blind method (11) 11
neoplasm metastasis (11) 11
therapy (11) 11
young adult (11) 11
analysis (10) 10
capecitabine (10) 10
combination (10) 10
fluorouracil - analogs & derivatives (10) 10
leucovorin - administration & dosage (10) 10
pancreatic cancer (10) 10
patients (10) 10
quality of life (10) 10
antineoplastic combined chemotherapy protocols - administration & dosage (9) 9
camptothecin - analogs & derivatives (9) 9
carcinoma (9) 9
drug administration schedule (9) 9
geochemistry & geophysics (9) 9
irinotecan (9) 9
ramucirumab (9) 9
1st-line treatment (8) 8
adenocarcinoma - pathology (8) 8
antineoplastic agents - therapeutic use (8) 8
cancer therapies (8) 8
medical and health sciences (8) 8
medicin och hälsovetenskap (8) 8
medicine, general & internal (8) 8
mutation (8) 8
organoplatinum compounds - administration & dosage (8) 8
original (8) 8
product development (8) 8
stomach neoplasms - drug therapy (8) 8
tumors (8) 8
5-fluorouracil (7) 7
adenocarcinoma - mortality (7) 7
adolescent (7) 7
antibodies, monoclonal - therapeutic use (7) 7
antimitotic agents (7) 7
antineoplastic agents (7) 7
camptothecin - administration & dosage (7) 7
cetuximab (7) 7
colorectal neoplasms - genetics (7) 7
enteral nutrition (7) 7
enteral nutrition - methods (7) 7
fluorouracil - adverse effects (7) 7
further section (7) 7
liver (7) 7
metastatic colorectal-cancer (7) 7
multicenter (7) 7
neutropenia (7) 7
pancreatic neoplasms - mortality (7) 7
placebo (7) 7
safety (7) 7
stomach cancer (7) 7
surgery (7) 7
antibodies, monoclonal - adverse effects (6) 6
cisplatin (6) 6
cisplatin - administration & dosage (6) 6
disease progression (6) 6
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet, The, ISSN 0140-6736, 2016, Volume 389, Issue 10064, pp. 56 - 66
Journal Article
by Fuchs, Charles S and Shitara, Kohei and Di Bartolomeo, Maria and Lonardi, Sara and Al-Batran, Salah-Eddin and Van Cutsem, Eric and Ilson, David H and Alsina, Maria and Chau, Ian and Lacy, Jill and Ducreux, Michel and Mendez, Guillermo Ariel and Alavez, Alejandro Molina and Takahari, Daisuke and Mansoor, Wasat and Enzinger, Peter C and Gorbounova, Vera and Wainberg, Zev A and Hegewisch-Becker, Susanna and Ferry, David and Lin, Ji and Carlesi, Roberto and Das, Mayukh and Shah, Manish A and Luft, Alexander V and Karaseva, Nina A and Kowalyszyn, Rubén Dario and Hernandez, Carlos Alberto and Csoszi, Tibor and De Vita, Ferdinando and Pfeiffer, Per and Sugimoto, Naotoshi and Kocsis, Judit and Csilla, Andràs and Bodoky, Gyorgy and Garnica Jaliffe, Georgina and Protsenko, Svetlana and Madi, Ayman and Wojcik, Elzbieta and Brenner, Baruch and Folprecht, Gunnar and Sarosiek, Tomasz and Peltola, Katriina Johanna and Bono, Peter and Ayala, Hubert and Aprile, Giuseppe and Gerardo, Cardellino Giovanni and Huitzil Melendez, Fidel David and Falcone, Alfredo and Di Costanzo, Francesco and Tehfe, Moustapha and Mineur, Laurent and García Alfonso, Pilar and Obermannova, Radka and Senellart, Hélène and Petty, Russell and Samuel, Leslie and Acs, Peter Istvan and Hussein, Maen Abdelkarim and Nechaeva, Marina N and Erdkamp, F.L.G and Won, Elizabeth and Bendell, Johanna Chock and Gallego Plazas, Javier and Lorenzen, Sylvie and Melichar, Bohuslav and Escudero, Miguel Angel and Pezet, Denis and Phelip, Jean-Marc and Kaen, Diego Lucas and Reeves, James A. Jr and Longo Muñoz, Federico and Madhusudan, Srinivasan and Barone, Carlo and Fein, Luis Enrique and Gomez Villanueva, Angel and Hebbar, Mohamed and Prausova, Jana and Visa Turmo, Laura and Vidal Barrull, Joana and Yilmaz, Mette Karen Nytoft and Beny, Alex and Van Laarhoven, H.M.W and DiCarlo, Brian Anthony and Esaki, Taito and Fujitani, Kazumasa and Geboes, Karen and Geva, Ravit and Kadowaki, Shigenori and Leong, Stephen and Machida, Nozomu and Raj, Moses Sundar and Ramirez Godinez, Francisco Javier and Ruzsa, Agnes and Ford, Hugo and Lawler, William E and Maisey, Nicolas Robert and Petera, Jiri and Shacham-Shmueli, Einat and Sinapi, Isabelle and ... and RAINFALL Study Grp and RAINFALL Study Group
The Lancet Oncology, ISSN 1470-2045, 03/2019, Volume 20, Issue 3, pp. 420 - 435
VEGF and VEGF receptor 2 (VEGFR-2)-mediated signalling and angiogenesis can contribute to the pathogenesis and progression of gastric cancer. We aimed to... 
EXPOSURE-RESPONSE | MULTICENTER | GASTROESOPHAGEAL JUNCTION | ANGIOGENESIS | ONCOLOGY | BEVACIZUMAB | COMBINATION | CANCER | EXPRESSION | CHEMOTHERAPY | ENDOTHELIAL GROWTH-FACTOR | Adenocarcinoma | Antimitotic agents | Care and treatment | Analysis | Clinical trials | Product development | Metastasis | Antineoplastic agents | Rain and rainfall
Journal Article
Annals of Oncology, ISSN 0923-7534, 05/2019, Volume 30, Issue 5, pp. 766 - 773
Abstract Background Pertuzumab combined with trastuzumab and docetaxel is the standard first-line therapy for HER2-positive metastatic breast cancer, based on... 
paclitaxel | first line | pertuzumab | dual HER2 blockade | HER2-positive | metastatic breast cancer | WEEKLY PACLITAXEL | ONCOLOGY | NAB-PACLITAXEL | PROGRESSION-FREE SURVIVAL | DOCETAXEL
Journal Article
Molecular Cancer Therapeutics, ISSN 1535-7163, 10/2017, Volume 16, Issue 10, pp. 2215 - 2222
Journal Article
by Mok, T. S. K and Paz-Ares, L and Wu, Y.-L and Novello, S and Juhasz, E and Aren, O and Sun, Y and Hirsh, V and Smit, E. F and Lathia, C and Ong, T. J and Pena, C and Pivot, X and Romieu, G and Bonnefoi, H and Pierga, J.-Y and Kerbrat, P and Guastalla, J.-P and Lortholary, A and Espie, M and Fumoleau, P and Serin, D and Jacquin, J.-P and Jouannaud, C and Rios, M and Abadie-Lacourtoisie, S and Tubiana-Mathieu, N and Cany, L and Catala, S and Khayat, D and Pauporte, I and Kramar, A and Goldhirsch, A and Piccart, M and Procter, M and De Azambuja, E and Weber, H and Untch, M and Smith, I. E and Gianni, L and Jackisch, C and Cameron, D and Bell, R and Dowsett, M and Gelber, R. D and Leyland-Jones, B and Baselga, J and Baum, M and Vaidya, J. S and Bulsara, M. K and Wenz, F and Tobias, J. S and Eiermann, W and Joseph, D and Pierga, J and Asselain, B and Alsafadi, S and Brain, E and Lerebours, F and Delaloge, S and Gentien, D and Servant, N and Sigal-Zafrani, B and Andre, F and Criscitiello, C and Azim, H. A and Agbor-Tarh, D and Eidtmann, H and Di Cosimo, S and Bradbury, I and Rubio, I. T and Semiglazov, V and Zurawski, B and Allerton, R and Fabi, A and Ciruelos, E and Parikh, R and DeSilvio, M and Santillana, S and Swaby, R and Verma, S and Miles, D and Krop, I and Welslau, M and Pegram, M and Oh, D and Dieras, V and Guardino, E and Fang, L and Lu, M. W and Olsen, S and Blackwell, K and Bachelot, T and Campone, M and Ballester, M. A and Commo, F and Goncalves, A and Levy, C and Ferrero, J and Lacroix, L and ... and on behalf of the TARGIT trialists group
Annals of Oncology, ISSN 0923-7534, 09/2012, Volume 23, Issue suppl 9, pp. ixe1 - ixe30
Journal Article
Journal Article
Annals of Oncology, ISSN 0923-7534, 11/2013, Volume 24, Issue suppl 9, pp. ix14 - ix14
Journal Article
Lancet, The, ISSN 0140-6736, 2016, Volume 387, Issue 10018, pp. 545 - 557
Summary Background Nanoliposomal irinotecan showed activity in a phase 2 study in patients with metastatic pancreatic ductal adenocarcinoma previously treated... 
Internal Medicine | PLUS GEMCITABINE | SURVIVAL | 5-FLUOROURACIL | MEDICINE, GENERAL & INTERNAL | ADENOCARCINOMA | 2ND-LINE CHEMOTHERAPY | OXALIPLATIN | PEP02 | DOCETAXEL | CARCINOMA | FOLFIRI | Leucovorin - administration & dosage | Humans | Middle Aged | Male | Fatigue - chemically induced | Diarrhea - chemically induced | Pancreatic Neoplasms - drug therapy | Neoplasm Metastasis | Fluorouracil - administration & dosage | Leucovorin - adverse effects | Fluorouracil - adverse effects | Camptothecin - administration & dosage | Carcinoma, Pancreatic Ductal - mortality | Deoxycytidine - adverse effects | Female | Pancreatic Neoplasms - mortality | Neutropenia - chemically induced | Camptothecin - analogs & derivatives | Camptothecin - adverse effects | Deoxycytidine - administration & dosage | Kaplan-Meier Estimate | Treatment Outcome | Carcinoma, Pancreatic Ductal - drug therapy | Irinotecan | Vomiting - chemically induced | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Aged | Liposomes | Deoxycytidine - analogs & derivatives | Antimitotic agents | Medical colleges | Pancreatic cancer | Leucovorin | Product development | Research institutes | Metastasis | Antineoplastic agents | Analysis | Antigens | Chemotherapy | Medical prognosis | Clinical trials | Drug dosages | Cancer therapies | Tumors | Adenocarcinoma | Slopes | Therapy | Gemcitabine | Toxicity | Metastases | Nanoparticles | Randomization | Motivation | Vomiting | Safety management | Toxic diseases | Neutropenia | Folinic acid | Lymphatic system | Medical treatment | Diarrhea | FDA approval | Survival | Patients | Acids | Equivalence | Interactive systems
Journal Article
by Borad, M and Reddy, S and Bahary, N and Uronis, H and Sigal, D. S and Cohn, A. L and Schelman, W and Stephenson, J and Eng, C and Ryan, D. P and Waddell, T. S and Reis-Filho, J and Gonzalez-De-Castro, D and Chau, I and Wotherspoon, A and Gupta, S and Saffery, C and Middleton, G and Wadsley, J and Cunningham, D and Ajani, J. A and Pantigoso, W. R and Bodoky, G and Moiseyenko, V and Lichinitser, M and Gorbunova, V. A and Vynnychenko, I and Lang, I and Falcon, S and Daniele, B and Rimassa, L and Porta, C and Borbath, I and Salvagni, S and van Laethem, J and van Vlierberghe, H and von Roemeling, R and Abbadessa, G and Santoro, A and Bronowicki, J and Ye, S and Kudo, M and Marrero, J and Venook, A and Nakajima, K and Lencioni, R and Iwase, H and Shimada, M and Tsuzuki, T and Ryuge, N and Kida, Y and Kato, B and Esaki, M and Tanaka, Y and Urata, N and Hamai, Y and Hihara, J and Emi, M and Aoki, Y and Okada, M and Ezoe, Y and Muto, M and Ueda, K and Ozaki, Y and Aoyama, I and Horimatsu, T and Morita, S and Miyamoto, S and Chiba, T and Xu, Y and Mao, W and Sun, X. J and Zheng, Y. D and Jiang, Y and Liu, J and Bria, E and De Manzoni, G and Beghelli, S and Tomezzoli, A and Barbi, S and Frizziero, M and Sperduti, I and Bersani, S and Tortora, G and Scarpa, A and Xia, J and Zhao, J and So, S and Pan, K and Wang, W and Li, X and Chen, J and Wang, D and Kurokawa, Y and Matsuura, N and Kimura, Y and Kawabata, R and Adachi, S and Fujita, J and Nishikawa, K and ... and on behalf of Phase 3 Principle Investigators
Annals of Oncology, ISSN 0923-7534, 09/2012, Volume 23, Issue suppl 9, pp. ix224 - ix257
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 04/2009, Volume 360, Issue 14, pp. 1408 - 1417
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2013, Volume 14, Issue 6, pp. 490 - 499
Journal Article